EW vs VRE · P/E 47, rev $1.39B vs rev $271.1M
Edwards Lifesciences Corp (EW) versus Veris Residential Inc (VRE) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Veris Residential Inc (VRE) is a reit - residential company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported VRE revenue for 2024-12-31 was $271.1M. Net income was -$26.7M. Revenue was up 4.1% from 2023-12-31 to 2024-12-31. VRE currently screens at market cap $1.61B.
EW currently screens at market cap $49.91B and trailing P/E 46.9. VRE currently screens at market cap $1.61B.
Not investment advice. Open the EW and VRE stock pages for the full models.
Not investment advice.